Skip to main content
. 2023 Oct 24;10(35):2303819. doi: 10.1002/advs.202303819

Figure 1.

Figure 1

Schematic illustration of the preparation and mechanism of OxP/R848@PLEL injectable thermosensitive hydrogel, which exerts synergetic chemo‐immunotherapy in the treatment of advanced CRC with diffuse PM, through induction of ICD, maturation of DCs, and polarization of TAMs.